Global Sevoflurane Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are increasing across the globe. A small molecule used for induction and maintenance of general anesthesia is known as Sevoflurane. It is non-inflammable, sweet smelling and highly fluorinated methyl isopropyl ether. Sevoflurane functions by depressing activity in the central nervous system (CNS) that causes loss of consciousness. Sevoflurane (2,2,2-trifluoro-1-[trifluoromethyl]ethyl fluoromethyl ether) is also called as fluoromethyl. It is used for both adult and paediatric patients in outpatient as well as inpatient surgery. The administration of Sevoflurane is through inhalation of the vaporised liquid. The other trade names of Sevoflurane include Ultane; Sevofluranum; 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane; Sevorane; Sojourn; Sevoflurano.
The factors that propel the growth of the Sevoflurane Market include increasing demand, rise in geriatric population, wide range of applications and rise in prevalence of diseases. On the other hand, there are also factors that may hamper the growth of the market such as side effects like nausea, increased cough, shivering, drowsiness, etc. Global Sevoflurane Market is classified on the basis of product type, application and geography. Global Sevoflurane Market is classified on the basis of product type as original drugs and generic drugs. Global Sevoflurane Market is classified on the basis of application as cardiac surgery, hepatobiliary surgery, neurosurgical procedure, urinary surgery, and others. Global Sevoflurane Market is classified on the basis of geography as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa.
The North American region consists of the U.S., and Canada. Latin America region consists of Mexico and Brazil. The Western European region consists of Germany, Italy, France, England and Spain. The Eastern European region consists of Poland and Russia. Asia Pacific region consists of China, India, ASEAN, Australia & New Zealand. The Middle East and Africa region consists of GCC, South Africa and North Africa. Some of the key players that fuel the growth of the Sevoflurane Industry include Abbott (AbbVie), Lunan, Maruishi, Piramal, Baxter, Hengrui and others.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Sevoflurane in these regions, from 2012 to 2022 (forecast), covering
• North America
• Southeast Asia
Global Sevoflurane market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Abbott (AbbVie)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Original Drugs
• Generic Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Sevoflurane for each application, including
• Urinary Surgery
• Cardiac Surgery
• Urinary Surgery
• Hepatobiliary Surgery
• Neurosurgical Procedure
Research Support Specialist, USA